ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

ADVENT CAPITAL MANAGEMENT /DE/'s Holding History (CIK: 0001097278)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 29,089,000 Value ($000) $31,502 Avg Close — Range —
Q1 2024
Shares 44,967,000 Value ($000) $42,592 Avg Close — Range —
Q4 2023
Shares 54,734,000 Value ($000) $54,050 Avg Close — Range —
Q3 2023
Shares 47,689,000 Value ($000) $44,232 Avg Close — Range —